VirB12 is a serological marker of Brucella infection in experimental and natural hosts

Hortensia G. Rolán, Andreas B. Den Hartigh, Melissa Kahl-McDonagh, Thomas Ficht, L. Garry Adams, Renee M Tsolis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The Brucella species type IV secretion system, encoded by the virB1-12 locus, is required for intracellular replication and persistent infection in vivo. The requirement of VirB proteins for infection suggests that they are expressed in vivo and may therefore represent serological markers of infection. To test this idea, we purified recombinant VirB1, VirB5, VirB11, and VirB12 and tested for their recognition by antibodies in sera from experimentally infected mice and goats by using an indirect enzyme-linked immunosorbent assay. Antibody responses to VirB12 but not to VirB1, VirB5, or VirB11 were detected in 20/20 mice experimentally inoculated with Brucella abortus and 12/12 goats experimentally infected with Brucella melitensis. The potential use of VirB12 as a serological tool for the diagnosis of brucellosis was evaluated in the natural bovine host. Serum samples from 145 cattle of known serology (29% negative and 71% positive) were analyzed for the production of antibody responses to VirB12. One hundred two cattle samples (70.3%) were positive for antibodies to VirB12, while 43 samples were negative (29.7%). A positive serological response to VirB12 correlated with positive serology to whole B. abortus antigen in 99% of samples tested. These results show that VirB12 is expressed during infection of both experimental and natural hosts of Brucella species, and they suggest that VirB12 may be a useful serodiagnostic marker for brucellosis.

Original languageEnglish (US)
Pages (from-to)208-214
Number of pages7
JournalClinical and Vaccine Immunology
Volume15
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Brucella
Brucella abortus
Brucellosis
Antibodies
Serology
Infection
Goats
Antibody Formation
Brucella melitensis
Immunosorbents
Serum
Assays
Enzyme-Linked Immunosorbent Assay
Antigens
Enzymes
Proteins

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)
  • Medicine(all)

Cite this

VirB12 is a serological marker of Brucella infection in experimental and natural hosts. / Rolán, Hortensia G.; Den Hartigh, Andreas B.; Kahl-McDonagh, Melissa; Ficht, Thomas; Adams, L. Garry; Tsolis, Renee M.

In: Clinical and Vaccine Immunology, Vol. 15, No. 2, 02.2008, p. 208-214.

Research output: Contribution to journalArticle

Rolán, Hortensia G. ; Den Hartigh, Andreas B. ; Kahl-McDonagh, Melissa ; Ficht, Thomas ; Adams, L. Garry ; Tsolis, Renee M. / VirB12 is a serological marker of Brucella infection in experimental and natural hosts. In: Clinical and Vaccine Immunology. 2008 ; Vol. 15, No. 2. pp. 208-214.
@article{53da6e7a06ac46a8aeef56983741cef9,
title = "VirB12 is a serological marker of Brucella infection in experimental and natural hosts",
abstract = "The Brucella species type IV secretion system, encoded by the virB1-12 locus, is required for intracellular replication and persistent infection in vivo. The requirement of VirB proteins for infection suggests that they are expressed in vivo and may therefore represent serological markers of infection. To test this idea, we purified recombinant VirB1, VirB5, VirB11, and VirB12 and tested for their recognition by antibodies in sera from experimentally infected mice and goats by using an indirect enzyme-linked immunosorbent assay. Antibody responses to VirB12 but not to VirB1, VirB5, or VirB11 were detected in 20/20 mice experimentally inoculated with Brucella abortus and 12/12 goats experimentally infected with Brucella melitensis. The potential use of VirB12 as a serological tool for the diagnosis of brucellosis was evaluated in the natural bovine host. Serum samples from 145 cattle of known serology (29{\%} negative and 71{\%} positive) were analyzed for the production of antibody responses to VirB12. One hundred two cattle samples (70.3{\%}) were positive for antibodies to VirB12, while 43 samples were negative (29.7{\%}). A positive serological response to VirB12 correlated with positive serology to whole B. abortus antigen in 99{\%} of samples tested. These results show that VirB12 is expressed during infection of both experimental and natural hosts of Brucella species, and they suggest that VirB12 may be a useful serodiagnostic marker for brucellosis.",
author = "Rol{\'a}n, {Hortensia G.} and {Den Hartigh}, {Andreas B.} and Melissa Kahl-McDonagh and Thomas Ficht and Adams, {L. Garry} and Tsolis, {Renee M}",
year = "2008",
month = "2",
doi = "10.1128/CVI.00374-07",
language = "English (US)",
volume = "15",
pages = "208--214",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - VirB12 is a serological marker of Brucella infection in experimental and natural hosts

AU - Rolán, Hortensia G.

AU - Den Hartigh, Andreas B.

AU - Kahl-McDonagh, Melissa

AU - Ficht, Thomas

AU - Adams, L. Garry

AU - Tsolis, Renee M

PY - 2008/2

Y1 - 2008/2

N2 - The Brucella species type IV secretion system, encoded by the virB1-12 locus, is required for intracellular replication and persistent infection in vivo. The requirement of VirB proteins for infection suggests that they are expressed in vivo and may therefore represent serological markers of infection. To test this idea, we purified recombinant VirB1, VirB5, VirB11, and VirB12 and tested for their recognition by antibodies in sera from experimentally infected mice and goats by using an indirect enzyme-linked immunosorbent assay. Antibody responses to VirB12 but not to VirB1, VirB5, or VirB11 were detected in 20/20 mice experimentally inoculated with Brucella abortus and 12/12 goats experimentally infected with Brucella melitensis. The potential use of VirB12 as a serological tool for the diagnosis of brucellosis was evaluated in the natural bovine host. Serum samples from 145 cattle of known serology (29% negative and 71% positive) were analyzed for the production of antibody responses to VirB12. One hundred two cattle samples (70.3%) were positive for antibodies to VirB12, while 43 samples were negative (29.7%). A positive serological response to VirB12 correlated with positive serology to whole B. abortus antigen in 99% of samples tested. These results show that VirB12 is expressed during infection of both experimental and natural hosts of Brucella species, and they suggest that VirB12 may be a useful serodiagnostic marker for brucellosis.

AB - The Brucella species type IV secretion system, encoded by the virB1-12 locus, is required for intracellular replication and persistent infection in vivo. The requirement of VirB proteins for infection suggests that they are expressed in vivo and may therefore represent serological markers of infection. To test this idea, we purified recombinant VirB1, VirB5, VirB11, and VirB12 and tested for their recognition by antibodies in sera from experimentally infected mice and goats by using an indirect enzyme-linked immunosorbent assay. Antibody responses to VirB12 but not to VirB1, VirB5, or VirB11 were detected in 20/20 mice experimentally inoculated with Brucella abortus and 12/12 goats experimentally infected with Brucella melitensis. The potential use of VirB12 as a serological tool for the diagnosis of brucellosis was evaluated in the natural bovine host. Serum samples from 145 cattle of known serology (29% negative and 71% positive) were analyzed for the production of antibody responses to VirB12. One hundred two cattle samples (70.3%) were positive for antibodies to VirB12, while 43 samples were negative (29.7%). A positive serological response to VirB12 correlated with positive serology to whole B. abortus antigen in 99% of samples tested. These results show that VirB12 is expressed during infection of both experimental and natural hosts of Brucella species, and they suggest that VirB12 may be a useful serodiagnostic marker for brucellosis.

UR - http://www.scopus.com/inward/record.url?scp=40449085112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449085112&partnerID=8YFLogxK

U2 - 10.1128/CVI.00374-07

DO - 10.1128/CVI.00374-07

M3 - Article

C2 - 18077620

AN - SCOPUS:40449085112

VL - 15

SP - 208

EP - 214

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 2

ER -